In the present study, Tan et al. [48] showed that high serum levels of haptoglobins (Haps) at baseline are associated with an inadequate response to MTX treatment after 12 weeks in early RA patients, but he could not predict the structural damage at the 1-year follow-up [48]. This evidence concerns the gene HP and rheumatoid arthritis.